April 9, 2019: Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid

April 9, 2019: Indivior Inc. Indicted for Fraudulently Marketing Prescription Opioid

http://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigation...

Source: Office of Criminal Investigations (OCI) Press Releases - May 16, 2019 Category: Medical Law Authors: DOJ Source Type: news

More News: Marketing | Medical Law